Immatics (IMTX) Payables (2019 - 2025)
Immatics' (IMTX) quarterly Payables came in at $21.9 million in Q4 2025, down 0.86% year-on-year from $22.1 million in Q4 2024, and down 0.86% quarter-over-quarter from $22.1 million in Q4 2024.
Immatics (IMTX) Payables (2019 - 2025) Analysis & Trends
Immatics has disclosed Payables across 7 years of filings, most recently posting $21.9 million for Q4 2025.
- Payables for Q4 2025 came in at $21.9 million, down 0.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.9 million (down 0.86% YoY), and the FY2025 annual result was $21.3 million, down 3.78% from the prior year.
- Payables came in at $21.9 million for Q4 2025 at Immatics, down from $22.1 million in the prior quarter.
- In the past five years, Payables ranged from a high of $27.1 million in Q4 2023 to a low of $11.3 million in Q2 2021.
- The 5-year median for Payables is $14.7 million (2023), against an average of $17.4 million.
- Across the five-year window, Payables jumped 103.6% in 2023 and decreased 18.46% in 2024, its largest moves.
- Immatics' Payables stood at $13.3 million in 2021, then climbed by 0.17% to $13.3 million in 2022, then surged by 103.6% to $27.1 million in 2023, then dropped by 18.46% to $22.1 million in 2024, then slipped by 0.86% to $21.9 million in 2025.
- The last three Payables figures came in at $21.9 million (Q4 2025), $22.1 million (Q4 2024), and $26.4 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 21.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.92 Mn |
| Dec 31, 2024 | 22.11 Mn |
| Mar 31, 2024 | 26.38 Mn |
| Dec 31, 2023 | 27.12 Mn |
| Sep 30, 2023 | 20.83 Mn |
| Jun 30, 2023 | 20.92 Mn |
| Mar 31, 2023 | 14.66 Mn |
| Dec 31, 2022 | 13.32 Mn |
| Sep 30, 2022 | 12.93 Mn |
| Jun 30, 2022 | 14.17 Mn |
| Mar 31, 2022 | 14.93 Mn |
| Dec 31, 2021 | 13.30 Mn |
| Sep 30, 2021 | 13.97 Mn |
| Jun 30, 2021 | 11.33 Mn |
| Mar 31, 2021 | 12.43 Mn |
| Dec 31, 2020 | 11.98 Mn |
| Sep 30, 2020 | 11.38 Mn |
| Jun 30, 2020 | 8.90 Mn |
| Dec 31, 2019 | 7.84 Mn |